These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The results of research on the antioxidant emoksipin in clinical eye diseases].
    Author: Egorov EA, Shvedova AA, Obraztsova IA.
    Journal: Vestn Oftalmol; 1989; 105(5):52-5. PubMed ID: 2595902.
    Abstract:
    Emoxipin, a new lipid peroxidation inhibitor, has been used in the treatment of various ophthalmic diseases. The drug is characterized by a retinal-protective and an additional fibrinolytic effects; it has been effectively used to preserve the visual function in glaucoma, to treat intraocular hemorrhages and retinal injuries with physical, chemical, or bacterial factors. A manifest effect has been observed in 87% of 106 patients (118 eyes) with various ocular abnormalities. Emoxipin is recommended for the treatment of a variety of ocular diseases.
    [Abstract] [Full Text] [Related] [New Search]